Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genomics and large scale phenotypic databases.

B R Winkelmann1

  • 1Heart Centre Ludwigshafen, Cardiovascular Molecular Genetics Laboratory, Bremser Str. 79, Ludwigshafen, D-67063, Germany. winkbr@gmx.de

Pharmacogenomics
|March 22, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

C-reactive protein and lipoprotein-associated phospholipase A2 in smokers and nonsmokers of the Ludwigshafen Risk and Cardiovascular Health study.

Advances in experimental medicine and biology·2014
Same author

Relationship between plasma aldosterone concentration and soluble cellular adhesion molecules in patients referred to coronary angiography.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2011
Same author

Genetic variants and haplotypes of lipoprotein associated phospholipase A2 and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study).

Journal of thrombosis and haemostasis : JTH·2008
Same author

The L162V polymorphism of the peroxisome proliferator activated receptor alpha gene (PPARA) is not associated with type 2 diabetes, BMI or body fat composition.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2008
Same author

Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk.

Journal of thrombosis and haemostasis : JTH·2007
Same author

The serotonin transporter gene polymorphism is not associated with smoking behavior.

The pharmacogenomics journal·2006
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
Same journal

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Pharmacogenomics·2026
See all related articles

Precise clinical data is crucial for understanding complex genetic diseases alongside genomic data. Large-scale projects like LURIC are building phenotypic databases to identify cardiovascular disease risk factors and markers.

Area of Science:

  • Genetics
  • Cardiovascular Disease Research
  • Bioinformatics

Background:

  • Advancements in human genome sequencing and molecular genetic tools necessitate parallel progress in clinical data precision.
  • Complex genetic diseases require comprehensive phenotypic data to complement extensive molecular genetic information.
  • Large-scale phenotypic databases are essential for advancing the study of complex genetic diseases.

Discussion:

  • The LUwigshafen Risk and Cardiovascular Health Study (LURIC) is constructing a large-scale phenotypic database for cardiovascular disease.
  • LURIC aims to identify novel genetic and environmental risk factors and markers for cardiovascular disease.
  • Understanding the pathophysiology of complex genetic diseases is a primary goal of LURIC.

Key Insights:

Related Experiment Videos

  • Integrating precise phenotypic data with genomic data is critical for disease research.
  • LURIC will facilitate the identification of new risk factors and prognostic markers for cardiovascular disease.
  • The study will enable research into functional genomics and pharmacogenomics.

    • Outlook:

    • LURIC's data will enhance the understanding of cardiovascular disease mechanisms.
    • The project will support the discovery of new biomarkers for disease risk and prognosis.
    • Pharmacogenomic insights from LURIC may personalize cardiovascular therapies.